YU896A - Farmaceutski sastav sa sadržajem lizozomskog dimera - Google Patents

Farmaceutski sastav sa sadržajem lizozomskog dimera

Info

Publication number
YU896A
YU896A YU896A YU896A YU896A YU 896 A YU896 A YU 896A YU 896 A YU896 A YU 896A YU 896 A YU896 A YU 896A YU 896 A YU896 A YU 896A
Authority
YU
Yugoslavia
Prior art keywords
lysozyme dimer
pharmaceutical compositions
compositions containing
diseases
containing lysozyme
Prior art date
Application number
YU896A
Other languages
English (en)
Inventor
Kiczka Witold
Original Assignee
Nika Health Products Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Limited filed Critical Nika Health Products Limited
Publication of YU896A publication Critical patent/YU896A/sh

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pronalazak se odnosi na farmaceutske sastave koji sadrže lizozimski dimer, prvenstveno visokog stepena čistoće, tj. sa oko 10% ili manje nepredvidjenih sporednih proizvoda, i na njihove nove primene. Takve primene uključuju lokalno, oralno i parenteralno davanje pomenutih sastava za nespecifičnu imunostimulaciju kao meru prevencije i/ili terapijskog lečenja humanih i životinjskih bolesti koje obuhvataju kancer, poremećaje u rastu kose, bolesti riba i bolesti pčela. Nespecifična stimulacija imunog sistema izaziva se samo jednom ili ponovnom primenom sastava lizozimskog dimera u koncentracijama od 5 do 500 g/kg telesne mase.
YU896A 1995-01-13 1996-01-10 Farmaceutski sastav sa sadržajem lizozomskog dimera YU896A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13

Publications (1)

Publication Number Publication Date
YU896A true YU896A (sh) 1999-07-28

Family

ID=8218903

Family Applications (1)

Application Number Title Priority Date Filing Date
YU896A YU896A (sh) 1995-01-13 1996-01-10 Farmaceutski sastav sa sadržajem lizozomskog dimera

Country Status (3)

Country Link
PE (1) PE4597A1 (sh)
YU (1) YU896A (sh)
ZA (1) ZA96127B (sh)

Also Published As

Publication number Publication date
PE4597A1 (es) 1997-01-13
ZA96127B (en) 1997-07-09

Similar Documents

Publication Publication Date Title
RU95113347A (ru) Спиропиперидины и их гомологи, способ получения, способ повышения уровней эндогенного гормона роста, способ лечения остеопороза, фармацевтическая композиция
RU94028670A (ru) Иммунопотенциирующие агенты, способы лечения иммунодефицитных млекопитающих, а также вирусных инфекций и рака у млекопитающих
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
FR2435471A1 (fr) Derives de dihydropyridine, procedes d'obtention et compositions pharmaceutiques en contenant
FI946073A0 (fi) Vitamiini D-sarjan, 20-asemassa modifioituja johdannaisia, menetelmä tällaisten johdannaisten valmistamiseksi, menetelmässä käytettäviä välituotteita, mainittuja johdannaisia sisältäviä farmaseuttisia valmisteita ja johdannaisten käyttö lääkeaineiden valmistamiseen
LV12766A (lv) Composition of l-dopa esters
PT1212060E (pt) Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinson
TR200101633T2 (tr) Farmasötik bileşim
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
MY132437A (en) New applications of lysozyme dimer
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
FR2356425A1 (fr) Application a titre de medicaments de derives organiques de la montmorillonite
YU896A (sh) Farmaceutski sastav sa sadržajem lizozomskog dimera
FR2413090A1 (fr) Preparation pharmaceutique a base d'ethylsuccinate d'erythromycine et son application contre les infections sensibles a l'erythromycine
OA07029A (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux.
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
HUP9801759A2 (hu) Neurodegeneratív betegségek kezelésére alkalmas benzamidok
MX9705246A (es) Nuevas aplicaciones de dimero de lisozina.
RU94042745A (ru) Способ профилактики, нормализации и лечения нарушений и болезней обмена веществ у молодняка крупного рогатого скота
JO1898B1 (en) New uses of the partial formula partial lysozyme
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
TH23121A (th) การประยุกต์แบบใหม่ของไลโซไซม์ ไคเมอร์
RU2150959C1 (ru) Способ профилактики и лечения желудочно-кишечных болезней у молодняка свиней